Clinical Trial Update: Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating mesenchymal stem cell therapy in pre-term infants with bronchopulmonary dysplasia; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: Bronchopulmonary Dysplasia | Phase 2 | Status: RECRUITING